Leukemia | Tumor

CURE’s leukemia page is a go-to resource for oncology news and updates in the world of leukemia Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in leukemia.

Blood Test Results May Offer Clues to Neurotoxicity Risk After CAR-T Cell Therapy in Cancer

September 22nd 2022

Patients with blood cancer who have higher levels of neurofilament light chains — which indicate brain injury — were found to be more likely to develop neurotoxicity after CAR-T cell therapy, according to recent research.

Jane Fonda Provides a Cancer Update, Old News Clipping Helps Patient With Leukemia Benefit from the Sept. 11 Victim Fund and More

September 9th 2022

From actress Jane Fonda giving an update on her cancer, to a patient with leukemia proving he was at the Sept. 11 attacks in New York City with an old newspaper clipping, here’s what’s happening in the cancer space this week.

Robin Roberts to Step Away from “GMA,” Former NFL Player Dies of Cancer and More

September 2nd 2022

From “Good Morning America” host Robin Roberts stepping away from the show after her partner finished breast cancer radiation to a former Tampa Bay Buccaneer dying of leukemia, here is what’s happening in the cancer space this week.

Early Findings of Novel Agent Show Promise in Treating Rare Blood Cancer

August 31st 2022

Patients with blastic plasmacytoid dendritic cell neoplasms can enroll in the ongoing CADENZA trial, which is investigating the safety and efficacy of the novel agent pivekimab sunirine in patients with the rare blood cancer.

FDA Lifts Partial Hold on Blood Cancer Trial, Patient Enrollment Allowed to Continue

August 31st 2022

The FDA’s decision allows patients with relapsed/refractory acute myeloid leukemia or high-risk myelodysplastic syndrome — types of blood cancer — to continue enrolling on the TakeAim Leukemia trial.

FDA Stops Study of Novel Blood Cancer Drug

August 23rd 2022

The Food and Drug Administration put a full clinical hold on a study of the novel drug FHD-286 in patients with acute myelogenous leukemia and myelodysplastic syndrome after study data showed an increase in a potentially fatal side effect.

First Patient Receives Investigational Cancer Drug-Combination for Relapsed/Refractory Acute Myeloid Leukemia

August 22nd 2022

Adding the investigational cancer drug lanraplenib to Xospata, if found to be effective, may broaden treatment options for patients with relapsed/refractory FLT3-mutated acute myeloid leukemia.

BBC’s ‘EastEnders’ Star Announces Cancer Diagnosis, Leukemia Survivor Embarks on Nation-Wide Bike Ride to Diversify Transplantation Donors and More

August 12th 2022

From “EastEnders” star Samantha Womack announcing her breast cancer diagnosis in a tribute to Olivia Newton-John to a famous fashion designer’s death from liver cancer, here’s what’s happening in the oncology space this week.

Crying Over a Movie, Cancer and Lost Innocence

August 11th 2022

“Love Story,” the story about a young woman who falls in love and then dies of cancer, affects me differently now than it did when I was a teenager and no experience with either love or cancer.

Leukemia Survivor Meets Country Music Singer Luke Combs, Sarcoma Nonprofit to Honor Minecraft YouTube Celebrity Technoblade and More

August 5th 2022

From the late YouTuber “Technoblade” being honored by the Sarcoma Foundation of America to a country singer making a leukemia survivor’s dreams come true, here’s what’s happening in the cancer space this week.

FDA Approves Tablet Version of Calquence to Treat Multiple Blood Cancers

August 5th 2022

The tablet version of Calquence, which was approved by the FDA for the treatment of chronic lymphocytic leukemia, small lymphocytic leukemia and relapsed/refractory mantle cell lymphoma, may be taken alongside other drugs to reduce gastric-related side effects.

Trial to Compare Safety and Efficacy of Novel Cell Therapy to Standard of Care in Patients With Rare Blood Cancers

August 3rd 2022

Enrollment has begun on a phase 3 clinical trial assessing the safety and efficacy of an investigational cell therapy in patients with acute myeloid leukemia, acute lymphocytic leukemia and myelodysplastic syndromes.

‘Leave it to Beaver’ Star Tony Dow Dies of Cancer, NFL Rookie to Miss First Season for Leukemia Treatment and More

July 29th 2022

From actors Tony Dow and David Warner dying from cancer to a cancer survivor rappelling a building in the name of awareness and fundraising, here’s what’s happening in the oncology space this week.

Novel Drug-Chemotherapy Combo After Stem Cell Transplant Associated With ‘Favorable Survival Outcomes’ in Group of Rare Blood Cancers

July 26th 2022

The findings support future studies of assessing the safety and efficacy of the novel drug-chemotherapy combination as a maintenance strategy following stem cell transplantation across a range of blood cancers, according to the study authors.

FDA to Speed Up Review of Novel CAR-T Cell Therapy for Rare Forms of Lymphoma and Leukemia

July 19th 2022

A first-in-human trial is investigating the safety and efficacy of the novel CAR-T cell therapy in patients relapsed or refractory T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma.

4 Recent FDA-Approved Blood Cancer Drugs That Patients May Have Missed

June 28th 2022

Spring 2022 brought in some landmark blood cancer approvals from the FDA. Here is a roundup of the therapies recently approved by the FDA that patients may have missed.

Tibsovo Plus Vidaza Is Beneficial for Patients With IDH1-Mutant Acute Myeloid Leukemia

June 4th 2022

Tibsovo plus Vidaza led to survival benefit for patients with IDH1-mutant acute myeloid leukemia, according to findings from the AGILE clinical trial.

To My Loved Ones, ‘You’ve Held the Pause Button Long Enough’ During My Cancer Journey

June 1st 2022

After I was diagnosed with cancer, I started to feel like a burden to my loved ones. So, I wrote a letter urging them to continue on with other aspects of their lives.

FDA Approves Tibsovo Plus Vidaza For Patients With Newly Diagnosed Acute Myeloid Leukemia

May 25th 2022

The combination of Tibsovo and Vidaza improved progression-free survival and overall survival and presented a favorable safety profile for older patients with acute myeloid leukemia.

FDA Approves Vidaza for Rare Pediatric Blood Cancer

May 23rd 2022

The FDA approved Vidaza for the treatment of pediatric patients with juvenile myelomonocytic leukemia.

PGA Tour Golfer Justin Thomas Urges People to Check for Melanoma, ‘One Life to Live’ and ‘As the World Turns’ Actress Marnie Schulenburg Dies from Cancer and More

May 20th 2022

From PGA Tour golfer Justin Thomas’ new sun-protection line to soap opera actress Marnie Schulenburg’s breast cancer death and the first child to receive CAR-T cell therapy celebrating 10 years cancer-free, here’s what’s happening in the cancer space this week.

Caring Deeply About Patients With Cancer, Colleagues and Clinical Research

May 6th 2022

Ilene Galinsky, ANP-BC, "had the courage to fiercely stand up for her patients’ best interests despite conventions of rank, seniority and arbitrary rules," a colleague said.

Patient With Leukemia Subtype Undergoes Stem Cell Transplant After Receiving Novel Monotherapy in Early-Phase Trial

April 1st 2022

Treatment with a novel monotherapy in a patient with relapsed/refractory acute myeloid leukemia was effective enough that a successful, as indicated by a significant reduction in bone marrow blasts, stem cell transplant was performed.

Uncharted Territory: How a Cancer Nurse Navigated Her Child’s Leukemia Diagnosis

February 3rd 2022

On this episode of the “Cancer Horizons” podcast, a cancer nurse explains how her son’s leukemia diagnosis transformed her work, her research and her outlook on life.

Wearable Remote Monitoring Device May Help Patients With Blood Cancers Identify When to Seek Follow-Up Care

January 20th 2022

Recent study results showed that the use of a remote monitoring device worn on the upper arm may help patients with blood cancers seek assistance for serious complications while receiving intensive treatments.

Expert Explores the Relationship Between Down Syndrome and Leukemia

January 6th 2022

In this episode of the “Cancer Horizons” podcast, an expert unpacks cancer risks for individuals with Down syndrome and analyzes the results of a recent study about mortality risks for childhood survivors later in life.

Mortality Risk Later in Life May Be Increased in Childhood Leukemia Survivors With Down Syndrome

January 3rd 2022

Patients with Down syndrome have an increased risk for leukemia during childhood, and toxicities related to treatment may be more common in this patient population.

Procter & Gamble Issues Product Recall Due to Cancer-Causing Chemical, Cancer Survivor Pays for Another Family’s Christmas and More

December 24th 2021

From a Procter & Gamble shampoo and conditioner recall due to the presence of benzene, a cancer-causing chemical, to heartwarming acts of holiday kindness for cancer survivors and their families, here’s what’s happening in the cancer landscape this week.

Third Full Dose of COVID-19 Vaccine Increases Antibody Response in Patients with Blood Cancers

December 23rd 2021

New findings show that 43% of patients with certain blood cancers produced COVID-19 antibodies after receiving a third full dose of the mRNA vaccine.

FDA Approves Orencia for GVHD Prevention After Hematopoietic Stem Cell Transplant

December 15th 2021

The Food and Drug Administration approved Orencia, which is commonly used to treat conditions like rheumatoid arthritis, to prevent acute graft-versus-host-disease in adults and children who underwent a hematopoietic stem cell transplant from an unrelated donor.